About Us

CellSpring develops minimally invasive tests to diagnose early stage cancer.  Our 3D Bloom technology effectively tricks cancer cells into revealing the molecular signature of Extracellular Vesicles (EVs) they secrete.  Diagnostic test kits under development will isolate and quantify cancer EVs that might be present in a patient's blood.

Detecting cancer early means catching it before a patient even has symptoms -- when the full gamut of therapeutic options is available. 

Cancer Cells in
Standard Conditions

Cancer Cells in
3D Bloom

20170317_A2780_zstackvideo_2.gif
The Future Of Cancer Detection
 
 

Meet the CellSpring Team

LinkedIn_Logo.webp

Christopher Millan, PhD

Devon_headshot_portrait.png
LinkedIn_Logo.webp

Devon Campbell Independent Director

LinkedIn_Logo.webp

Queralt Vallmajó, PhD

Eberli.png
LinkedIn_Logo.webp

Daniel Eberli, MD/PhD
Clinical Collaborator

Latest News

 

Awards & Supporters

At CellSpring, we are highly grateful for all the support received from our partners.

MC_Winner_logo.png
MC_Winner_logo.png
usz_newLogo_big.jpeg
usz_newLogo_big.jpeg
30under30_2016_logo.jpg
30under30_2016_logo.jpg